James E. Bradner Amgen Inc (AMGN) insider trading activity
James E. Bradner is EVP, R&D, & Chief Sci. Officer of AMGEN INC. Currently has a direct ownership of 25,438 shares of AMGN, which is worth approximately $7.07 Million. The most recent transaction as insider was on May 07, 2024, when has been sold 2,863 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.4K
0%
3M change
n/a
12M change
Total Value Held
$7.07 Million
JEB
James E. Bradner
EVP, R&D, & Chief Sci. Officer
Thousand Oaks, CA